Preview

Regulatory Research and Medicine Evaluation

Advanced search

Role and Safety of Excipients in Syrups (Review)

https://doi.org/10.30895/1991-2919-2025-15-2-190-205

Abstract

INTRODUCTION. Syrups are an important dosage form used in medical practice, particularly in paediatrics. As of January 2024, there are 212 medicinal products formulated as syrups approved in the Russian Federation. The effi­cacy, safety, and quality of syrups are determined by their composition, including excipients.

AIM. This study aimed to analyse and systematise data on the role and safety of excipients in syrups included in the Russian State Register of Medicines.

DISCUSSION. This article reviews the major groups of excipients present in syrups, including sweeteners, preservatives, solvents, thickeners, pH modifiers, buffering agents, antioxidants, and colourants. The most prevalent group of excipients is sweeteners, including sucrose (66.51%), sorbitol (29.25%), and sodium saccharin (10.85%). Sucrose contributes to tooth decay and is contraindicated in patients with diabetes and obesity. Sorbitol may cause gastrointestinal disorders. Data on the long-term safety of artificial sweeteners are contradictory. Therefore, sweeteners should be selected rationally. The most widely used preservatives are parabens, including methylparaben (31.60%) and propylparaben (20.28%). Propyl­paraben exhibits potential oestrogenic activity, which makes methylparaben the para­ben of choice. Solvents and co-solvents include water, glycerol (25.94%), ethanol (24.53%), and propylene glycol (20.75%). Ethanol and propylene glycol can cause severe central nervous system disorders. The most commonly used thickener is hydroxyethyl cellulose (5.19%). Cellulose derivatives are considered safe but may have a laxative effect if consumed in excess. The most popular colourant is Sunset Yellow (7.54%). The lack of data on the safety of many colourants emphasises the need for their rational selection.

CONCLUSIONS. By analysing summaries of product characteristics and patient information leaflets for syrups available in the Russian State Register of Medicines, the authors have systematised data on the role, safety, and acceptable daily intake of excipients in used syrups, classified these excipients, and calculated the frequency of their use. The findings suggest that the current approaches to selecting excipients for syrups should be revised to minimise potential risks and to enhance the safety of medicinal products.

About the Authors

V. V. Kosenko
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation

Valentina V. Kosenko - Cand. Sci. (Pharm.).

8/2 Petrovsky Blvd, Moscow 127051



Ya. S. Novikov
Kazan State Medical University
Russian Federation

Yaroslav S. Novikov

49 Butlerov St., Kazan 420012



S. N. Egorova
Kazan State Medical University
Russian Federation

Svetlana N. Egorova - Dr. Sci. (Pharm.), Professor.

49 Butlerov St., Kazan 420012



V. A. Evteev
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation

Vladimir A. Evteev

8/2 Petrovsky Blvd, Moscow 127051



N. D. Bunyatyan
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation

Natalya D. Bunyatyan - Dr. Sci. (Pharm.), Professor.

8/2 Petrovsky Blvd, Moscow 127051



References

1. Petkova V, Georgieva D, Dimitrov M, Nikolova I. Off-­label prescribing in pediatric population — literature review for 2012–2022. Pharmaceutics. 2023;15(12):2652. https://doi.org/10.3390/pharmaceutics15122652

2. Malkawi WA, AlRafayah E, AlHazabreh M, AbuLaila S, Al-Ghananeem AM. Formulation challenges and strategies to develop pediatric dosage forms. Children. 2022;9(4):488. https://doi.org/10.3390/children9040488

3. Rusz C-M, Ősz B-E, Jîtcă G, Miklos A, Bătrînu M-G, Imre S. Off-label medication: From a simple concept to complex practical aspects. Int J Environ Res Public Health. 2021;18(19):10447. https://doi.org/10.3390/ijerph181910447

4. Moreira M, Sarraguça M. How can oral paediatric formulations be improved? A challenge for the XXI century. Int J Pharm. 2020;590:119905. https://doi.org/10.1016/j.ijpharm.2020.119905

5. Meyers RS. The past, present, and future of oral dosage forms for children. J Pediatr Pharmacol Ther. 2024;29(1):22–31. https://doi.org/10.5863/1551-6776-29.1.22

6. Saito J, Agrawal A, Patravale V, Pandya A, Orubu S, Zhao M, et al. The current states, challenges, ongoing efforts, and future perspectives of pharmaceutical excipients in pediatric patients in each country and region. Children (Basel). 2022;9(4):453. https://doi.org/10.3390/children9040453

7. Kim ME, Stepanova EF, Evseyeva SB. Syrups: Composition, technology, current state of research (review). Pharmacy & Pharmacology. 2014;2(3):7–14 (In Russ.). https://doi.org/10.19163/2307-9266-2014-2-3(4)-7-14

8. Meyers RS, Thackray J, Matson KL, McPherson C, Lubsch L, Hellinga RC, Hoff DS. Key potentially inappropriate drugs in pediatrics: The KIDs list. J Pediatr Pharmacol Ther. 2020; 25(3):175–91. https://doi.org/10.5863/1551-6776-25.3.175

9. Al Humaid J. Sweetener content and cariogenic potential of pediatric oral medications: A literature review. Int J Health Sci (Qassim). 2018;12(3):75–82. PMCID: PMC5969777

10. Wee M, Tan V, Forde C. A comparison of psychophysical dose-response behaviour across 16 sweeteners. Nutrients. 2018;10(11):1632. https://doi.org/10.3390/nu10111632

11. Cavagnari BM. Non-caloric sweeteners and body weight. Medicina (Buenos Aires). 2019;79(2):115–22. PMID: 31048277

12. Iizuka K. Is the use of artificial sweeteners beneficial for patients with diabetes mellitus? The advantages and disadvantages of artificial sweeteners. Nutrients. 2022;14(21):4446. https://doi.org/10.3390/nu14214446

13. Dulal MM, Islam MK, Chowdhury AA, Chowdhury JA. Prevention of cap-locking of syrup product by treating the manufacturing process of sugar syrup with citric acid monohydrate. Bangladesh Pharm J. 2016;19(2):190–6. https://doi.org/10.3329/bpj.v19i2.29279

14. White JR Jr. Sugar. Clin Diabetes. 2018;36(1):74–6. https://doi.org/10.2337/cd17-0084

15. Belayneh A, Tadese E, Molla F. Safety and biopharmaceutical challenges of excipients in off-label pediatric formulations. Int J Gen Med. 2020;13:1051–66. https://doi.org/10.2147/IJGM.S280330

16. Rouaz K, Chiclana-Rodríguez B, Nardi-Ricart A, Sune-Pou M, Mercade-Frutos D, Sune-Negre JM, et al. Excipients in the paediatric population: A review. Pharmaceutics. 2021;13(3):387. https://doi.org/10.3390/pharmaceutics13030387

17. Tan VWK, Wee MSM, Tomic O, Forde CG. Temporal sweetness and side tastes profiles of 16 sweeteners using temporal check-all-that-apply (TCATA). Food Res Int. 2019;121:39–47. https://doi.org/10.1016/j.foodres.2019.03.019

18. Grembecka M. Sugar alcohols — their role in the mo­dern world of sweeteners: A review. Eur Food Res Technol. 2015;241:1–14. https://doi.org/10.1007/s00217-015-2437-7

19. Radeloff MA, Beck RHF. Polyols — more than sweeteners. Sugar Industry/Zuckerindustrie. 2013;138(4):226–34. https://doi.org/10.36961/si14095

20. Zhang W, Chen J, Chen Q, Wu H, Mu W. Sugar alcohols derived from lactose: Lactitol, galactitol, and sorbitol. Appl Microbiol Biotechnol. 2020;104(22):9487–95. https://doi.org/10.1007/s00253-020-10929-w

21. Bauditz J, Norman K, Biering H, Lochs H, Pirlich M. Severe weight loss caused by chewing gum. BMJ. 2008;336(7635):96–7. https://doi.org/10.1136/bmj.39280. 657350.BE

22. Razzak Mahmood AA, Al-Juboori SB. A review: Saccharin discovery, synthesis, and applications. Ibn AL-Haitham J Pure Appl Sci. 2020;33(2):43–61. https://doi.org/10.30526/33.2.2442

23. More TA, Sheikh Z, Ali A. Artificial sweeteners and their health implications: A review. Biosci Biotech Res Asia. 2021;18(2). https://doi.org/10.13005/bbra/2910

24. Chattopadhyay S, Raychaudhuri U, Chakraborty R. Artificial sweeteners — a review. J Food Sci Technol. 2014;51(4):611–21. https://doi.org/10.1007/s13197-011-0571-1

25. Saad A. A review on potential toxicity of artificial sweeteners vs safety of stevia: A natural bio-sweetener. J Biol Agric Health Care. 2014;(4):137–47.

26. Magnuson BA, Roberts A, Nestmann ER. Critical review of the current literature on the safety of sucralose. Food Chem Toxicol. 2017;106(Pt A):324–55. https://doi.org/10.1016/j.fct.2017.05.047

27. Shaher SAA, Mihailescu DF, Amuzescu B. Aspartame safety as a food sweetener and related health hazards. Nutrients. 2023;15(16):3627. https://doi.org/10.3390/nu15163627

28. Petric Z, Ružić J, Žuntar I. The controversies of parabens — an overview nowadays. Acta Pharm. 2021;71(1):17–32. https://doi.org/10.2478/acph-2021-0001

29. Alaba P, Cañete E, Pantalan B, Taguba J, Yu L, Faller E. Toxic effects of paraben and its relevance in cosmetics: A review. Int J Res. 2022;3(5):3425–66.

30. Lincho J, Martins RC, Gomes J. Paraben compounds — Part I: An overview of their characteristics, detection, and impacts. Appl Sci. 2021;11(5):2307. https://doi.org/10.3390/app11052307

31. Walczak-Nowicka ŁJ, Herbet M. Sodium benzoate — harmfulness and potential use in therapies for disorders related to the nervous system: A review. Nutrients. 2022;14(7):1497. https://doi.org/10.3390/nu14071497

32. Raharjo S. Toxicological aspects of sorbates: A review. agriTECH. 2017;14(3):35–41. https://doi.org/10.22146/agritech.19294

33. Chilbule A, Singh R, Mann B, Arora S, Sharma R, Singh Rao P. Development and validation of an analytical method for determination of bronopol and kathon preservative in milk. J Food Sci Technol. 2019;56(6):3170–6. https://doi.org/10.1007/s13197-019-03807-5

34. Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, et al. Safety assessment of glycerin as used in cosmetics. Int J Toxicol. 2019;38(3_suppl):6S–22S. https://doi.org/10.1177/1091581819883820

35. Eccles R, Mallefet P. Soothing properties of glycerol in cough syrups for acute cough due to common cold. Pharmacy (Basel). 2017;5(1):4. https://doi.org/10.3390/pharmacy5010004

36. Marek E, Kraft WK. Ethanol pharmacokinetics in neonates and infants. Curr Ther Res. 2014;76:90–7. https://doi.org/10.1016/j.curtheres.2014.09.002

37. Zuccotti GV, Fabiano V. Safety issues with ethanol as an excipient in drugs intended for pediatric use. Expert Opin Drug Saf. 2011;10(4):499–502. https://doi.org/10.1517/14740338.2011.565328

38. Mohammadi Z, Shalavi S, Jafarzadeh H. Ethylenediamine­tetraacetic acid in endodontics. Eur J Dent. 2013;7(Suppl 1):S135–S142. https://doi.org/10.4103/1305-7456.119091

39. Lanigan RS, Yamarik TA. Final report on the safety assessment of EDTA, calcium disodium EDTA, diammonium EDTA, dipotassium EDTA, disodium EDTA, TEA-EDTA, tetrasodium EDTA, tripotassium EDTA, trisodium EDTA, HEDTA, and trisodium HEDTA. Int J Toxicol. 2002;21 Suppl 2:95–142. https://doi.org/10.1080/10915810290096522

40. Jujare VK, Dantuluri A, Liu Y, Durig T. Hydroxyethylcellulose as a versatile viscosity modifier in the development of sugar-free, elegant oral liquid formulations. Int J Curr Res Chem Pharm Sci. 2023;10:1–23. https://doi.org/10.22192/ijcrcps.2023.10.04.001

41. Eccles R. What is the role of over 100 excipients in over-the-counter (OTC) cough medicines? Lung. 2020;198(5):727–34. https://doi.org/10.1007/s00408-020-00390-x

42. Arai K, Shikata T. Hydration/dehydration behavior of hydr­oxy­ethyl cellulose ether in aqueous solution. Molecules. 2020; 25(20):4726. https://doi.org/10.3390/molecules25204726

43. Rahman MS, Hasan MS, Nitai AS, Nam S, Karmakar AK, Ahsan MS, et al. Recent developments of carboxymethyl cellulose. Polymers (Basel). 2021;13(8):1345. https://doi.org/10.3390/polym13081345

44. Zarmpi P, Flanagan T, Meehan E, Mann J, Fotaki N. Biopharmaceutical understanding of excipient variability on drug apparent solubility based on drug physicochemical properties: Case study — hypromellose (HPMC). AAPS J. 2020;22(2):49. https://doi.org/10.1208/s12248-019-0411-1

45. Kruk K, Szekalska M, Basa A, Winnicka K. The impact of hypromellose on pharmaceutical properties of alginate microparticles as novel drug carriers for posaconazole. Int J Mol Sci. 2023;24(13):10793. https://doi.org/10.3390/ijms241310793

46. Binisha K, Remya SB, Prasobh GR, Jasbin Nisha S, Soorya S. A review on hypromellose as pharmaceutical excipient for oromucosal drug delivery. Int J Pharm Pharm Res. 2023;27(2):289–303.

47. Final report on the safety assessment of hydroxy­ethylcellulose, hydroxypropylcellulose, methylcellulose, hydroxypropyl methylcellulose, and cellulose gum. J Am Coll Toxicol. 1986;5(3):1–59. https://doi.org/10.3109/10915818609141925

48. Mortensen A, Aguilar F, Crebelli R, Di Domenico A, Frutos MJ, Galtier P, et al. Re-evaluation of xanthan gum (E 415) as a food additive. EFSA J. 2017;15(7):e04909. https://doi.org/10.2903/j.efsa.2017.4909

49. Cortes H, Caballero-Florán IH, Mendoza-Muñoz N, Escutia-Guadarrama L, Figueroa-González G, Reyes-Hernández OD, et al. Xanthan gum in drug release. Cell Mol Biol (Noisy-le-Grand). 2020;66(4):199–207. PMID: 32583796

50. Furtado I, Sydney E, Rodrigues S, Sydney A. Xanthan gum: Applications, challenges, and advantages of this asset of biotechnological origin. Biotechnol Res Innov. 2022;6:e202204. https://doi.org/10.4322/biori.202205

51. Patil N. Tragacanth gum-based hydrogels for drug delivery and tissue engineering applications. Front Mater. 2024;11. https://doi.org/10.3389/fmats.2024.1296399

52. Tripathy S, Das M. Guar gum: Present status and applications. J Pharm Sci Innov. 2013;2(4):24–8. https://doi.org/10.7897/2277-4572.02447

53. Abka-Khajouei R, Tounsi L, Shahabi N, Patel AK, Abdelkafi S, Michaud P. Structures, properties and applications of alginates. Mar Drugs. 2022;20(6):364. https://doi.org/10.3390/md20060364

54. Biswal PK, Mishra MK, Bhadouriya AS, Yadav VK. An updated review on colorants as the pharmaceutical excipients. Int J Pharm Chem Biol Sci. 2015;5(4):1004–17.

55. Barciela P, Perez-Vazquez A, Prieto MA. Azo dyes in the food industry: Features, classification, toxicity, alternatives, and regulation. Food Chem Toxicol. 2023;178:113935. https://doi.org/10.1016/j.fct.2023.113935

56. Amchova P, Kotolova H, Ruda-Kucerova J. Health safety issues of synthetic food colorants. Regul Toxicol Pharmacol. 2015;73(3):914–22. https://doi.org/10.1016/j.yrtph.2015.09.026


Supplementary files

Review

For citations:


Kosenko V.V., Novikov Ya.S., Egorova S.N., Evteev V.A., Bunyatyan N.D. Role and Safety of Excipients in Syrups (Review). Regulatory Research and Medicine Evaluation. 2025;15(2):190-205. (In Russ.) https://doi.org/10.30895/1991-2919-2025-15-2-190-205

Views: 457


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 3034-3062 (Print)
ISSN 3034-3453 (Online)